FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care (HTG682)Product type:GuidanceProgramme:HealthTech guidancePublished: 7 June 2023
MRI-based technologies for assessing non-alcoholic fatty liver disease (HTG655)Product type:GuidanceProgramme:HealthTech guidancePublished: 12 January 2023
Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C (HTG385)Product type:GuidanceProgramme:HealthTech guidanceLast updated: 17 January 2020Published: 23 September 2015
SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver (HTG291)Product type:GuidanceProgramme:HealthTech guidancePublished: 29 August 2012